凝血酶激活的纤溶抑制物与糖尿病关系的研究进展

1. Bajzar L.Manuel R.Nesheim ME Purification and characterization of TAFI,a thrombin-activatable fibrinolysis inhibitor 1995
2. Mosnier LO.Buijtennhuijs P.Marx PF Identifcation of thrombin activatable fibrinolysis inhibior(TAFI) in human platelets 2003(12)
3. Frere C.Morange PE.Saut N Quantification of thrombin activatable fibrinolysis inhibitor(TAFI) gene polymorphism effects on plasma levels of TAFI measured with assays insensitive to isoform-dependent artefact 2005(2)
4. Mosnier LO.von dem Borne PA.Meijers JC Plasma TAFI levels influence the clot lysis time in healthy individuals in the presence of an intact intrinsic pathway of coagulation 1998(5)
5. Watanabe T.Minakami H.Sakata Y Changes in activity of plasma thrombin activatable fibrinolysis inhibitor in pregnancy 2004(1)
6. Schatteman KA.Goossens FJ.Scharpe SS Proteolytic activation of purified human procarboxypeptidase U 2000(1-2)
7. Bouma BN.Meijers JC Thrombin-activatable fibrinolysis inhibitor(TAFI plasma procarboxypeptidase B,procarboxypeptidase R,procarboxypeptidase U) 2003(7)
8. 谢爽.王鸿利 凝血酶激活纤溶抑制物的研究进展 [期刊论文] -国外医学(临床生物化学与检验学分册)2003(3)
9. Yaon Y.Gabazza EC.Hori Y Association between plasma thrombin-activatable fibrinolysis inhibitor levels and activated protein C in normotensive type 2 diabetic patients 2002(7)
10. 董宁征.吴成亮.季顺东.江淼.阮长耿 PAI-1和TAFIa对机体内源性纤溶的调控作用 [期刊论文] -江苏医药2004(10)
11. Yamada T.Sato A.Nishimori T Importance of hypercoagulability over hyperglycemia for vascular complication in type 2 diabetes 2000(1)
12. Yano Y.Kitagawa N.Gabazza EC Increased plasma thrombin-activatable fibrinolysis inhibitor levels in normotensive type 2 diabetic patients with microalbuminuria 2003
13. 钟兰君.李晓娜.丁进芳.王凤兰.李芳文.张兴旺 血浆纤溶抑制物与2型糖尿病患者凝血及纤溶功能变化的关系 [期刊论文] -国际检验医学杂志2006(5)
14. Hori Y.Gabazza EC.Yano Y Insulin resistance is associated with increased circulating level of thrombin-activatable fibrinolysis inhibitor in type 2 diabetic patients 2002(2)
15. 李晓娜.丁进芳.王凤兰.钟兰君.李芳文.边玉军.张兴旺 凝血酶激活的纤溶抑制物与2型糖尿病微量白蛋白尿症的关系 [期刊论文] -中华检验医学杂志2006(7)
16. Aso Y.Wakabayashi S.Yamamoto R Metabolic syndrome accompanied by hypercholesterolemia is strongly associated with proinflammatory state and impairment of fibrinolysis in patients with type 2 diabetes 2005
17. Harmanci A.Kandemir N.Dagdelen S Thrombin-activatable fibrinolysis inhibitor activity and global fibrinolytic capacity in type 1 diabetes evidence for normal fibrinolytic state 2006
18. Klement P.Liao P.Bajzar L A novel approach to arterial thrombolysis 1999(8)
19. Nagashina M.Werner M.Wang M An inhibitor of actived thrombin-activatable fibrinolysis inhibitor potentiates tissue-type plasminogen activator-induced thrombolysis in a rabbit jugular vein thrombolysis model 2000(4)

更多...

1. 谢玮.刘敏涓.冯莹.周旭红 凝血、纤溶系统功能与2型糖尿病关系的研究 [期刊论文] -血栓与止血学2007(04)

更多...